Cargando…
Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis
BACKGROUND: Cancer metastasis and drug resistance have traditionally been studied separately, though these two lethal pathological phenomena almost always occur concurrently. Brain metastasis occurs in a large proportion of lung cancer patients (~ 30%). Once diagnosed, patients have a poor prognosis...
Autores principales: | Shah, Neal, Liu, Zhongwei, Tallman, Rachel M., Mohammad, Afroz, Sprowls, Samuel A., Saralkar, Pushkar A., Vickers, Schuyler D., Pinti, Mark V., Gao, Weimin, Lockman, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137432/ https://www.ncbi.nlm.nih.gov/pubmed/32264860 http://dx.doi.org/10.1186/s12885-020-06808-2 |
Ejemplares similares
-
A Review of Mathematics Determining Solute Uptake at the Blood–Brain Barrier in Normal and Pathological Conditions
por: Sprowls, Samuel A., et al.
Publicado: (2021) -
Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene
por: Butler, Christopher, et al.
Publicado: (2020) -
Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
por: Mohammad, Afroz S., et al.
Publicado: (2018) -
BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?
por: Blethen, Kathryn, et al.
Publicado: (2023) -
Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy
por: Arsiwala, Tasneem A., et al.
Publicado: (2023)